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Zoledronic acid (ZA) belongs to bisphosphonates (BPs), drugs administered to 
treat resorptive bone diseases. Although ZA is largely used in the clinical practice, 
significant adverse effects of ZA, such as osteonecrosis of the jaw (ONJ), were record-
ed. 
The aim of this work was to evaluate the role of Nitric Oxide (NO) in the in vitro 
response of Human Gingival Fibroblasts (HGFs) to 1, 5, 10 and 100µM ZA.
HGFs morphology was evaluated through phase contrast microscopy and live/
dead staining; MTT and ELISA assays were applied to measure cell viability, Colla-
gen Type I and IL6 secretion. ROS production and mitochondrial membrane potential 
were evaluated by flow cytometry; NO production and NOS activity by spectropho-
tometric analysis; eNOS and nNOS expression by fluorescence microscopy.
Viable fibroblasts are evidenced in control sample while floating dead cells and 
cells close to detachment phase in ZA treated sample along with decreased level of 
Collagen Type I. Control sample shows higher number of viable cells respect to ZA 
treated one and ROS production increases when ZA is added. Released NO in ZA 
treated sample appears higher and NO overproduction is related to increased nNOS 
activity. IL 6 secretion level is higher in ZA treated sample than in control one.
Our results suggest ROS involvement in NO overproduction, due to nNOS 
recruitment, both at low and high doses. In turn, NO release seems to be able to trig-
ger the inflammatory response only when high doses are administered. 
